These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 8129277)

  • 1. What is a human teratogen: clinical and epidemiological criteria.
    Bertollini R; Pagano M; Mastroiacovo P
    Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic methods in the search for causes of human birth defects.
    Ferencz C; Loffredo C; Wilson PD
    Teratology; 2000 Apr; 61(4):243-5. PubMed ID: 10716741
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of dysmorphology in birth defects epidemiology.
    Friedman JM
    Teratology; 1992 Feb; 45(2):187-93. PubMed ID: 1615428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.
    Khoury MJ; Becerra JE; Cordero JF; Erickson JD
    Pediatrics; 1989 Oct; 84(4):658-65. PubMed ID: 2674881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological issues in the epidemiological study of the teratogenicity of drugs.
    Källén BA
    Congenit Anom (Kyoto); 2005 Jun; 45(2):44-51. PubMed ID: 15904431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of associations between birth defects and suspected human teratogens.
    Khoury MJ; James LM; Lynberg MC
    Am J Med Genet; 1991 Sep; 40(4):500-5. PubMed ID: 1746618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing surveillance for human teratogenicity: a model approach.
    Chambers CD; Braddock SR; Briggs GG; Einarson A; Johnson YR; Miller RK; Polifka JE; Robinson LK; Stepanuk K; Lyons Jones K
    Teratology; 2001 Nov; 64(5):252-61. PubMed ID: 11745831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for predicting human birth defects.
    Clayson DB
    Prog Clin Biol Res; 1985; 163C():197-203. PubMed ID: 3991622
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of known environmental teratogens: drugs and chemicals.
    Beckman DA; Brent RL
    Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens.
    Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF
    Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichloroethylene and dichloroethylene: a critical review of teratogenicity.
    Hardin BD; Kelman BJ; Brent RL
    Birth Defects Res A Clin Mol Teratol; 2005 Dec; 73(12):931-55. PubMed ID: 16342278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complexities of solving the problem of human malformations.
    Brent RL
    Clin Perinatol; 1986 Sep; 13(3):491-503. PubMed ID: 3533363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity.
    Timmermann G; Acs N; Bánhidy F; Czeizel AE
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):815-25. PubMed ID: 19551756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools.
    Uhl K; Trontell A; Kennedy D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):337-48. PubMed ID: 16953517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.